HuagongsheHuagongshe Chemistry Print Report · For research reference only
(25R)-16-oxo-26-hydroxycholesterol → (25R)-16-oxo-26-phthalimidocholesterol
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (25R)-16-oxo-26-hydroxycholesterol | HCID 13873472 | — |
| Reactant | Phthalimide potassium salt | HCID 24194345 | — |
| Product | (25R)-16-oxo-26-phthalimidocholesterol | HCID 9832896 | — |
Reaction Steps
According to Scheme 2, (25R)-16β-26-dihydroxycholesterol (2) is selectively oxidized at the C-16 position to produce (25R)-16-oxo-26-hydroxycholesterol (9). Compound (9) is then converted to the monotosylate (25R)-16-oxo-26-hydroxycholesterol 26-tosylate (8) directly or by indirect means by solvolysis of (25R)-16-oxo-26-hydroxycholesterol 3β,26-diotsylate (7) derived from Compound 9. The C-26 tosylate of compound (8) is then displaced with potassium phthalimide to produce key compound (5) as described above. ##STR2##
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05274088 |
| Source dataset | uspto-grants-1993_12 |
| ORD ID | ord-c4c6cbbd8f6843448cc23d08800fcf38 |
| Source note | uspto-grants-1993_12 |